Immunohistochemical Distributions of the Tissue Kallikrein-Kinin System in Ischemic and Non-Ischemic Mouse Heart

Journal of Cardiovascular Pharmacology

Volumn 42, Issue SUPPL. 1, 2003, Pages

  Yano, Yoko ^a   Ozono, Ryoji ^a   Nakashima, Hidekatu ^a   Oishi, Yoshihiko ^a   Kambe, Masayuki ^a   Hosoi, Kazuo ^b   Oshima, Tetsuya ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Immunohistochemistry; Kallikrein; Myocardial ischemia

Indexed keywords

ANTIBODY; BRADYKININ ANTIBODY; BRADYKININ B2 RECEPTOR; EPITOPE; KALLIKREIN; KININOGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; EVALUATION; FIBROBLAST; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; IMMUNOHISTOCHEMISTRY; KALLIKREIN KININ SYSTEM; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

EID: 0344154592     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200312001-00012     Document Type: Conference Paper

References (20)

1. Bhoola KD, Figueroa CD, Worthy K, et al. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 1992;44:1-80.
2. Nolly H, Carbini LA, Scicli G, et al. A local kallikrein-kinin system is present in rat hearts. Hypertension 1994;23:919-23.
3. Nolly H, Carretero OA, Scicli AG, et al. Kallikrein release by vascular tissue. Am J Physiol Heart Circ Physiol 1993:265: H1209-H1214.
4. Tschope C, Koch M, Spillmann F, et al. Upregulation of the cardiac bradykinin B2 receptors after myocardial infarction. Immunopharmacology 1999;44:111-17.
5. Yang XP, Liu YH, Scicli GM, et al. Study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen-deficient rats. Hypertension 1997;30:735-40.
6. Parratt JR, Vegh A, Papp JG, et al. Bradykinin as an endogenous myocardial protective substance with particular reference to ischemic preconditioning - a brief review of the evidence. Can J Physiol Pharmacol 1995;73:837-42.
7. Pinto YM, Bader M, Pesquero JB, et al. Increased kallikrein expression protects against cardiac ischemia. FASEB J 2000;14:1861-3.
8. Yoshida H, Zhang JJ, Chao L, et al. Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Hypertension 2000;35:25-31.
9. Linz W, Wiemer G, Scholkens BA, et al. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies. Diabetes 1996;45(Suppl. 1): S51-S58.
10. Xiong W, Chen LM, Woodley-Miller C, et al. Identification, purification, and localization of tissue kallikrein in rat heart. Biochem J 1990;267:639-46.
11. Hosoi K, Tsunasawa S, Kurihara K, et al. Identification of mK1, a true tissue (glandular) kallikrein of mouse submandibular gland: tissue distribution and a comparison of kinin-releasing activity with other submandibular kallikreins. J Biochem (Tokyo) 1994;115:137-43.
12. Kurabuchi S, Hosoi K, Gresik EW, et al. Developmental and androgenic regulation of the immunocytochemical distribution of mK1, a true tissue kallikrein, in the granular convoluted tubule of the mouse submandibular gland. J Histochem Cytochem 2002;50:135-46.
13. Oishi Y, Ozono R, Yano Y, et al. Cardioprotective role of AT2 receptor in post-infarction left ventricular remodeling. Hypertension 2003;41:814-18.
14. Kurisu S, Ozono R, Oshima T, et al. Cardiac angiotensin II type 2 receptor activates kinin/NO system and inhibits fibrosis. Hypertension 2003;41:99-107.
15. Meneton P, Bloch-Faure M, Hagege AA, et al. Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice. Proc Natl Acad Sci USA 2001;98:2634-9.
16. Carretero OA, Oza NB, Piwonska A, et al. Measurement of urinary kallikrein activity by kinin radioimmunoassay. Biochem Pharmacol 1976;25:2265-70.
17. Nolly H, Scicli AG, Scicli G. et al. Characterization of a kininogenase from rat vascular tissue resembling tissue kallikrein. Circ Res 1985;56:816-21.
18. Liu YH, Yang XP, Sharov VG, et al. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats. Hypertension 1996;27:7-13.
19. Liu YH, Yang XP, Mehta D, et al. Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats. Am J Physiol Heart Circ Physiol 2000;278: H507-H514.
20. Figueroa CD, Marchant A, Novoa U, et al. Differential distribution of bradykinin B2 receptors in the rat and human cardiovascular system. Hypertension 2001;37:110-20.